Thomas Wakim
Stock Analyst at Bell Potter
(0.07)
# 4,383
Out of 4,421 analysts
95
Total ratings
26%
Success rate
-21.8%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.20 | $2.81 | +14.08% | 4 | Jun 11, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Buy | $0.16 | $0.10 | +60.00% | 13 | May 25, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $19.00 → $17.00 | $9.95 | +70.85% | 5 | May 24, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $155.00 → $100.00 | $109.76 | -8.89% | 9 | May 11, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $22.00 | $13.27 | +65.85% | 14 | May 8, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.06 | $0.023 | +160.87% | 4 | May 4, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.13 → $0.12 | $0.038 | +215.79% | 12 | May 1, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.10 | $0.067 | +49.25% | 8 | Apr 7, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.30 | $1.42 | +61.97% | 7 | Mar 17, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $0.65 → $0.07 | $0.05 | +40.00% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.42 | $0.12 | +250.00% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.09 → $0.10 | $0.018 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.60 | n/a | 4 | Apr 1, 2025 |
Cogstate Limited
Jun 11, 2026
Maintained: Buy
Price Target: $3.20
Current: $2.81
Upside: +14.08%
Alcidion Group Limited
May 25, 2026
Maintained: Buy
Price Target: $0.16
Current: $0.10
Upside: +60.00%
Clinuvel Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $19.00 → $17.00
Current: $9.95
Upside: +70.85%
CSL Limited
May 11, 2026
Maintained: Hold
Price Target: $155.00 → $100.00
Current: $109.76
Upside: -8.89%
Neuren Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: $22.00
Current: $13.27
Upside: +65.85%
Syntara Limited
May 4, 2026
Maintained: Buy
Price Target: $0.06
Current: $0.023
Upside: +160.87%
Microba Life Sciences Limited
May 1, 2026
Maintained: Buy
Price Target: $0.13 → $0.12
Current: $0.038
Upside: +215.79%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.067
Upside: +49.25%
PYC Therapeutics Limited
Mar 17, 2026
Maintained: Buy
Price Target: $2.30
Current: $1.42
Upside: +61.97%
Immutep Limited
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.05
Upside: +40.00%
Aug 7, 2025
Maintained: Buy
Price Target: $0.42
Current: $0.12
Upside: +250.00%
May 13, 2025
Maintained: Hold
Price Target: $0.09 → $0.10
Current: $0.018
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.60
Upside: n/a